Drug-resistant epilepsy pipeline
Mar 22, 2021
Which Pharma Companies are Transforming the Drug-Resistant Epilepsy Market Landscape?
Which Pharma Companies are Transforming the Drug-Resistant Epilepsy Market Landscape? In the United States, more than 2.5 million people are living with Epilepsy, out of which approximately 1 million continue to experience seizures despite adequate treatment with antiseizure drugs. Known as Drug-resistant epilep...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
